Inspire Medical Systems, Inc. (INSP) Gross margin 2016–2025
Inspire Medical Systems, Inc. (INSP) gross margin by fiscal year — reported gross profit divided by reported revenue.
85.4%FY2025 · since FY2016: 76.2% → 85.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 85.4% | +0.7 pp |
| FY2024 | 84.7% | +0.1 pp |
| FY2023 | 84.5% | +0.8 pp |
| FY2022 | 83.8% | -2.0 pp |
| FY2021 | 85.7% | +1.0 pp |
| FY2020 | 84.7% | +1.4 pp |
| FY2019 | 83.4% | +3.2 pp |
| FY2018 | 80.1% | +1.2 pp |
| FY2017 | 78.9% | +2.7 pp |
| FY2016 | 76.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More INSP financial trends
INSP RevenueINSP Net incomeINSP Net marginINSP Gross profitINSP Operating incomeINSP Operating marginINSP Operating cash flowINSP Free cash flowINSP Capital expendituresINSP Return on equityINSP Stock buybacksINSP Dividends paidINSP Total assetsINSP Total liabilitiesINSP Shareholders’ equityINSP overview →